- Financial Times•17 hours ago
Drugs that selectively destroy cancer cells by destabilising their DNA will be developed in a £6m project funded by the Wellcome Trust at the University of Sussex, in collaboration with AstraZeneca. The ...
Pre-Market: 31.280.15 (0.48%) as of 4:23 AM EDT
|Bid||31.15 x 1500|
|Ask||31.16 x 2200|
|52wk Range||26.97 - 34.88|
|Day's Range||30.40 - 31.23|
|Avg Vol (3m)||5,053,734|
As of 4:03 PM EDT. Market closed.